The Role and Participation of Immune Cells in the Endometrial Tumor Microenvironment

Endometrial cancer (EC) is an immunogenic disease, and in recent years, immunotherapy has shown benefit in the treatment of recurrent and advanced EC. This authors discuss the key molecular pathways associated with the intra-tumoral immune response and involvement of circulatory signaling molecules.